Carbon Reduction Commitment

AI Rehab Ltd

Last updated: 1st January 2025

AI Rehab Ltd recognises the importance of sustainability to the NHS, patients, and wider society. The company is committed to reducing its environmental impact over time and to aligning its approach with UK Government climate policy and NHS England’s Net Zero ambitions.

Commitment to net zero

AI Rehab Ltd commits to achieving net zero greenhouse gas emissions by 2050, in line with:

• UK Government net zero targets, and
• NHS England’s ambition to reach net zero for emissions it controls by 2040 and for emissions it can influence by 2045.

The company will review and update its carbon reduction approach on an annual basis, taking account of changes in business activities and scale.

Organisational context

AI Rehab Ltd is a UK-based digital health company developing and supplying technology to support home-based rehabilitation, including the Slider system used within NHS knee rehabilitation pathways.

As a small and growing organisation:

• AI Rehab Ltd does not operate manufacturing facilities
• AI Rehab Ltd does not operate a vehicle fleet
• Direct operational emissions are currently limited

The company’s environmental impact is primarily associated with indirect emissions related to digital services, supply chains, and logistics.

Emissions scope

AI Rehab Ltd’s approach is informed by the Greenhouse Gas (GHG) Protocol and reflects NHS categorisation of emissions.

Scope 1 – Direct emissions

Direct emissions are currently minimal or negligible. The company has no owned manufacturing facilities, fleet vehicles, or on-site fuel combustion.

Scope 2 – Purchased energy

Emissions associated with purchased electricity relate primarily to office activities and cloud-based services. Where feasible, the company seeks to use service providers with stated renewable energy or energy efficiency commitments.

Scope 3 – Indirect emissions

Scope 3 emissions represent the most material category and include:

• Manufacture of single-patient rehabilitation devices
• Distribution and logistics
• Cloud hosting and data processing
• Business travel
• Wider supply chain activities

As the company scales, AI Rehab Ltd will seek to improve data capture and oversight across relevant Scope 3 categories, consistent with NHS Net Zero guidance.

Alignment with NHS Net Zero objectives

AI Rehab Ltd’s technology is designed to support models of care that are consistent with NHS Net Zero priorities, including the use of home-based rehabilitation and digital monitoring. These approaches have the potential to reduce reliance on repeated in-person outpatient visits where clinically appropriate, supporting more efficient service delivery.

Software updates are delivered digitally, reducing the need for hardware replacement.

Carbon reduction actions

AI Rehab Ltd’s current carbon reduction actions include:

Product and service design

• Design of lightweight, single-patient devices
• Software-led updates to extend product functionality without additional hardware

Operations

• Remote and hybrid working practices where appropriate
• Minimisation of business travel
• Predominantly digital documentation and communication

Supply chain and logistics

• Engagement with suppliers as volumes scale to encourage lower-carbon manufacturing and packaging
• Review of logistics and distribution arrangements to minimise transport-related emissions where feasible

Monitoring and review

AI Rehab Ltd will review its Carbon Reduction Commitment annually and update this page to reflect material changes in business activities, scale, or sustainability priorities.

Governance

Responsibility for sustainability and carbon reduction sits with the senior management team of AI Rehab Ltd, with oversight at company director level.

Contact

For queries regarding this Carbon Reduction Commitment, please contact:
📧 contact@airehab.com

Note for NICE and NHS readers

This page constitutes AI Rehab Ltd’s public Carbon Reduction Commitment, published in line with NICE requirements. The information provided is for transparency only and does not form part of the clinical or economic assessment.